Understand the source comparison
VIP for Sale: Research Peptide Purity Comparison
Researchers evaluating VIP for sale across suppliers face inconsistent documentation standards, variable synthesis quality, and significant price differences that don't always correlate with actual purity. The table below compares key quality indicators across
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers evaluating VIP for sale across suppliers face inconsistent documentation standards, variable synthesis quality, and significant price differences that don't always correlate with actual purity. The table below compares key quality indicators across typical supplier tiers.
- Research-Grade (e.g., Real Peptides)
- >98% (chromatogram provided)
- ESI-MS with exact molecular weight confirmation
- Insulated shipper with gel packs, <48hr transit
- Yes. Unique CoA per production lot
- $85–$120
- Suitable for reproducible research; purity and handling meet institutional standards
- Mid-Tier Research Supplier
- 95–98% (stated, chromatogram often generic)
- Sometimes provided, not always batch-specific
- Ice pack in standard envelope, variable transit
- Generic CoA across batches
- $60–$85
- Adequate for preliminary screening; verification recommended before critical experiments
- Budget/Generic Supplier
- 90–95% (stated, no analytical data)
- Rarely provided
- Ambient shipping or inconsistent cooling
- No CoA or generic certificate only
- $30–$50
- High failure risk; purity and identity unverified; significant batch-to-batch variation likely
- Custom Synthesis Houses (academic/pharma)
- >99% (full analytical package)
- Yes, with NMR and MS/MS fragmentation
- Dry ice, validated cold-chain logistics
- Comprehensive batch record with synthesis details
- $200–$400+
- Gold standard for critical research; cost-prohibitive for routine use
- The Professional Assessment column reflects real-world reproducibility outcomes. Research-grade suppliers like Real Peptides occupy the cost-benefit sweet spot: institutional-quality peptides at prices that allow repeated experiments without budget constraints forcing researchers into lower-quality alternatives that compromise data integrity.
- Price alone is not a reliable quality indicator. Some mid-tier suppliers charge premium prices while providing generic CoAs and ambient shipping. Conversely, extremely low prices (<$40/vial for a 28-residue peptide) signal synthesis shortcuts: lower coupling efficiency, no post-synthesis purification, or improper folding. The downstream cost is failed experiments, wasted animal models, and irreproducible findings.